CARDIO DIAGNOSTICS HOLDINGS, INC. Financials Cardio Diagnostics Holdings, Inc.
Equities
CDIO
US14159C1036
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7 USD | +1.43% |
|
-13.95% | -71.89% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 10.09 | 51.09 | 14.9 | - |
| Enterprise Value (EV) 1 | 10.09 | 51.09 | 14.9 | 14.9 |
| P/E ratio | -0.7 x | -3.77 x | -1.61 x | -2.06 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 10,616 x | 2,993 x | 24.3 x | 8.28 x |
| EV / Revenue | 10,616 x | 2,993 x | 24.3 x | 8.28 x |
| EV / EBITDA | - | - | - | - |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 9,515 | 20,517 | 21,591 | - |
| Reference price 2 | 1.060 | 2.490 | 0.7000 | 0.7000 |
| Announcement Date | 3/31/23 | 4/1/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | 0.00095 | 0.0171 | 0.6125 | 1.8 |
| EBITDA | - | - | - | - |
| EBIT 1 | -4.548 | -7.242 | -8.552 | -7.473 |
| Operating Margin | -478,784.21% | -42,428% | -1,396.22% | -415.17% |
| Earnings before Tax (EBT) 1 | -4.661 | -8.377 | -9.515 | -7.473 |
| Net income 1 | -4.661 | -8.377 | -9.515 | -7.473 |
| Net margin | -490,630.53% | -49,073.4% | -1,553.52% | -415.17% |
| EPS 2 | -1.510 | -0.6600 | -0.4350 | -0.3400 |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/31/23 | 4/1/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 0.00095 | - | 0.00173 | 0.01 | 0.00531 | 0.0159 | 0.1125 | 0.175 | 0.3 | 0.35 | 0.45 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | -0.1653 | -2.378 | -1.703 | -2.553 | -1.444 | -1.542 | -4.158 | -2.069 | -2.18 | -2.398 | -1.843 | -1.932 |
| Operating Margin | - | - | -250,322.11% | - | -147,580.35% | -14,398.7% | -29,039.55% | -26,102.01% | -1,839.02% | -1,245.94% | -799.38% | -526.57% | -429.33% |
| Earnings before Tax (EBT) 1 | - | 0.2023 | -2.378 | -1.033 | -4.023 | -1.932 | -1.389 | -4.164 | -2.369 | -2.48 | -2.701 | -1.843 | -1.932 |
| Net income 1 | -0.842 | 0.2023 | -2.378 | -1.033 | -4.023 | -1.932 | -1.389 | -4.164 | -2.369 | -2.48 | -2.701 | -1.843 | -1.932 |
| Net margin | - | - | -250,322.11% | - | -232,538.15% | -19,266% | -26,156.87% | -26,136.72% | -2,105.69% | -1,417.37% | -900.22% | -526.57% | -429.33% |
| EPS 2 | -0.5300 | 0.0200 | -0.0600 | -0.1100 | -0.3900 | -0.1600 | - | -0.2000 | -0.1050 | -0.1150 | -0.1200 | -0.0800 | -0.0900 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/23/22 | 11/7/22 | 3/31/23 | 5/15/23 | 8/14/23 | 11/13/23 | 4/1/24 | 5/15/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | - | 0.5 | 0.5 |
| Capex / Sales | - | - | 81.63% | 27.78% |
| Announcement Date | 3/31/23 | 4/1/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7
USD
Average target price
4.675
USD
Spread / Average Target
+567.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -71.89% | 14.9M | |
| +8.63% | 115B | |
| +13.17% | 107B | |
| -12.76% | 22.31B | |
| -3.99% | 21.6B | |
| -7.19% | 18.23B | |
| -39.93% | 17.62B | |
| +6.67% | 14.26B | |
| +33.90% | 12.37B | |
| -28.60% | 8.28B |
- Stock Market
- Equities
- CDIO Stock
- Financials Cardio Diagnostics Holdings, Inc.